TONIX PHARMACEUTICALS HOLDING CORP
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$5.10
-3.41%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-44.8%
3 months
-52.2%
6 months
-62.5%
1 year
-71.8%
Year to date
-67.3%
52-week range
$5.10 – $19.89
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$87.5M
P/E
-0.5
P/B
0.4
P/S
3
Revenue
$29.1M
Net income
-$159.67M
Diluted EPS
-13.11
Gross margin
83.80%
Net margin
-548.60%
Return on equity
-69.00%
Total debt
$1.27M
Cash
$176.23M
Free cash flow
-$158.11M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $13.54M | -$40.55M | 94.80% | -299.40% | -$42.83M |
| Mar 31, 2026 | $6.88M | -$40.19M | 77.10% | -584.40% | -$44.01M |
| Dec 31, 2025 | $5.39M | -$46.91M | 80.40% | -870.30% | -$41.52M |
| Sep 30, 2025 | $3.29M | -$32.01M | 58.40% | -972.90% | -$29.74M |
| Jun 30, 2025 | $2M | -$28.27M | -63.80% | -1415.00% | -$15.36M |
| Mar 31, 2025 | $2.43M | -$16.83M | 61.20% | -692.80% | -$16.59M |
| Dec 31, 2024 | $2.58M | -$22.11M | 54.20% | -856.20% | -$14.63M |
| Sep 30, 2024 | $2.82M | -$14.21M | 44.90% | -503.60% | -$18.81M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent TNXP news
All market newsNo ticker-linked stories are in the current archive.